SubsidieMeestersA novel and accurate emotion recognition system for real-time and continuous patient monitoring in psychiatry
Cephalgo has developed an AI-driven emotion tracker to remotely monitor patients' emotional status, enhancing treatment effectiveness and reducing trial and error in psychiatric care.
Projectdetails
Introduction
150M people suffer from mental disorders in Europe, and this number is sharply increasing. There are not enough psychiatrists to cope with the situation: a psychiatrist sees 1,000 patients in sessions separated every 3-4 months.
Challenges in Psychiatry
Psychiatrists have no way to know if a patient's treatment is working and if there is any risk of relapse or suicide between sessions. A patient's emotional status gives insights into treatment effectiveness and diagnosis of major depressive disorder, but there are no accurate tools to monitor emotions remotely and continuously.
Cephalgo's Solution
Cephalgo has solved this challenge and developed the first accurate, remote, and continuous emotion tracker to monitor treatment effectiveness and predict the best course of treatment for a given patient profile.
Technology Overview
Combining speech analysis and an AI-driven emotion recognition algorithm, our AI detects emotions with high accuracy and predicts the best treatment to reduce the trial-and-error approach currently employed in psychiatry.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.497.708 |
| Totale projectbegroting | € 3.568.155 |
Tijdlijn
| Startdatum | 1-11-2023 |
| Einddatum | 30-4-2026 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- CEPHALGOpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Advanced Remote Continuous patient Health mANaGemEnt SoLutionCheckpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients. | EIC Accelerator | € 2.436.000 | 2023 | Details |
Revolutionizing remote care of chronic disease patients – an interoperable and smart monitoring platformThe HumanITcare platform is an AI-driven solution that integrates data from various medical devices into EHRs, reducing patient visits by 40% and enhancing chronic disease management in Europe. | EIC Accelerator | € 2.438.800 | 2022 | Details |
A simple blood test to choose the best treatment for each patient with depression.RxMine uses stem cell technology and machine learning to personalize antidepressant treatment, aiming to significantly reduce healthcare costs and improve patient outcomes for major depressive disorder. | EIC Accelerator | € 2.499.000 | 2022 | Details |
Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsordersThe project aims to develop and clinically validate Smart Skin technology for home-based monitoring of sleep disorders, replacing costly PSG and facilitating commercialization in Europe. | EIC Accelerator | € 2.457.113 | 2023 | Details |
Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AIImplicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools. | EIC Accelerator | € 2.488.359 | 2025 | Details |
Advanced Remote Continuous patient Health mANaGemEnt SoLution
Checkpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients.
Revolutionizing remote care of chronic disease patients – an interoperable and smart monitoring platform
The HumanITcare platform is an AI-driven solution that integrates data from various medical devices into EHRs, reducing patient visits by 40% and enhancing chronic disease management in Europe.
A simple blood test to choose the best treatment for each patient with depression.
RxMine uses stem cell technology and machine learning to personalize antidepressant treatment, aiming to significantly reduce healthcare costs and improve patient outcomes for major depressive disorder.
Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsorders
The project aims to develop and clinically validate Smart Skin technology for home-based monitoring of sleep disorders, replacing costly PSG and facilitating commercialization in Europe.
Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI
Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Intelligent psychodiagnostisch platform: Sensor ondersteunde diagnostiekHet project ontwikkelt een diagnostisch platform met camera en slimme software om verbale en non-verbale communicatie te analyseren voor nauwkeurigere psychiatrische diagnoses. | Mkb-innovati... | € 139.335 | 2016 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC Consolid... | € 1.999.875 | 2025 | Details |
Biometrisch VR meting, analyse & data ontsluit-systeemDit R&D-project ontwikkelt een metingsysteem voor real-time biometrische data om stress te monitoren en de samenwerking tussen gebruikers en zorgprofessionals te verbeteren via PGO's. | Mkb-innovati... | € 169.730 | 2020 | Details |
Empathic RobotHet project onderzoekt de haalbaarheid van een empathische robot die emoties herkent en de zelfstandigheid van kwetsbare doelgroepen bevordert. | Mkb-innovati... | € 20.000 | 2021 | Details |
Adaptieve behandeling van angststoornissenOntwikkeling van een innovatief platform dat VR en biofeedback integreert voor gepersonaliseerde behandeling van angststoornissen, met als doel kostenbesparing en effectiviteit in de geestelijke gezondheidszorg. | Mkb-innovati... | € 172.773 | 2017 | Details |
Intelligent psychodiagnostisch platform: Sensor ondersteunde diagnostiek
Het project ontwikkelt een diagnostisch platform met camera en slimme software om verbale en non-verbale communicatie te analyseren voor nauwkeurigere psychiatrische diagnoses.
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
Biometrisch VR meting, analyse & data ontsluit-systeem
Dit R&D-project ontwikkelt een metingsysteem voor real-time biometrische data om stress te monitoren en de samenwerking tussen gebruikers en zorgprofessionals te verbeteren via PGO's.
Empathic Robot
Het project onderzoekt de haalbaarheid van een empathische robot die emoties herkent en de zelfstandigheid van kwetsbare doelgroepen bevordert.
Adaptieve behandeling van angststoornissen
Ontwikkeling van een innovatief platform dat VR en biofeedback integreert voor gepersonaliseerde behandeling van angststoornissen, met als doel kostenbesparing en effectiviteit in de geestelijke gezondheidszorg.